New York bill S03351 adds tianeptine sodium to Schedule II of controlled substances.
New York bill S03351 amends the public health law to add tianeptine sodium to Schedule II of controlled substances. This change will subject tianeptine sodium to stricter regulations and controls, similar to other substances in Schedule II. The bill's provisions will take effect 90 days after it becomes law.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.